Erythrina sacleuxii
Erythrina sacleuxii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Erythrina sacleuxii is a significant medicinal plant frequently studied for its diverse therapeutic potential in traditional medicine. Research has particularly focused on its efficacy in managing complex health conditions such as cancer and leukemia. To harness these biological properties, practitioners often utilize the specific medicinal components found within the plant's root system. The most potent bioactive compounds are typically extracted from the prepared root bark to ensure maximum potency. Understanding the application of this root bark provides valuable insights into its role as a natural agent against malignant diseases.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Taxonomy
Erythrina sacleuxii is a remarkable botanical specimen that belongs to the vast kingdom Plantae. Within this expansive group, the plant is specifically classified under the class Equisetopsida. It falls under the order Fabales, a grouping that helps define its unique biological characteristics. Furthermore, it is a member of the diverse family Fabaceae, which is known for its significant ecological contributions. Ultimately, this species is identified by its distinct placement within the genus Erythrina.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina sacleuxii is a distinctive plant species with a specific geographical presence within the African continent. Its natural distribution is primarily concentrated throughout the regions of East Tropical Africa. Within this broader territory, the plant can be found growing in the landscapes of Kenya. It also maintains a notable presence across the borders in Tanzania. These regional connections highlight the specific ecological niche this species occupies in East Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrina sacleuxii is a self-supporting tree that establishes a sturdy presence in its natural habitat. This species typically develops a robust growth form capable of reaching a maximum height of 15 meters. Its structural integrity allows it to stand independently as it matures into a significant feature of the landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Erythrina sacleuxii demonstrates significant potential in the treatment of cancer and leukemia. Research into Kenyan indigenous medicinal plants has highlighted its effectiveness through the study of various extracts. Specifically, the root bark of this plant exhibited more than 50% cell inhibition against the CCRF-CEM leukemia cell line. These findings were observed when using both n-hexane-CH2Cl2 and CH2Cl2-MeOH solvent systems. Consequently, the plant's cytotoxic properties support its traditional use in managing these serious diseases.
Preparations
Erythrina sacleuxii is prepared as root bark for medicinal purposes within the Kenyan flora. This specific part of the plant was utilized to create extracts for cytotoxicity testing against human CCRF-CEM leukemia cells. During the study, root bark extracts from this species were obtained using both 50% n-hexane-CH2Cl2 and 50% CH2Cl2-MeOH solvent systems. These preparations demonstrated significant inhibitory effects, showing more than 50% cell inhibition at a single concentration of 10μg/mL. Consequently, the use of Erythrina sacleuxii root bark serves as a key component in investigating traditional treatments for cancer-related diseases.
Parts used
Erythrina sacleuxii is one of the many Kenyan medicinal plants investigated for its potential efficacy against human leukemia cells. In this scientific study, researchers examined various components of the flora to determine their cytotoxic properties. Specifically, the research highlighted that the root bark of Erythrina sacleuxii exhibited significant inhibitory effects when extracted with certain solvent systems. This finding contributes to a broader understanding of how different plant parts can be utilized in traditional ethnopharmacology. Ultimately, such data helps to authenticate the long-standing medicinal uses of these species in managing complex diseases.